The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology. The fourth leading cause of ...

which reduces the risk of cancer by protecting against HPV types that lead to cervical cancer. For mRNA vaccines, there are various ways that they can be used against cancer, including in adoptive ...

The outcomes of this trial help confirm that cisplatin chemotherapy given adjuvantly with radiotherapy is not a superior alternative ,” said Sang Young Ryu, MD.

A cervical teratoma is a rare, large tumor that develops on a baby's neck while in the womb. How a major surgery can help the ...

Globally, there are more than 476 million Indigenous peoples residing in over 90 countries who represent at least 5000 unique cultures, and who constitute approximately 6% of the global population.1 ...

Apr. 9, 2025 — Scientists have developed a new method for identifying and classifying pancreatic cancer cell subtypes based on sugars found on the outside of cancer cells. These sugars ...

Curious connections? You’re inexplicably drawn to someone in your social circle as Venus and Uranus harmonize. If a friendship becomes something more, it will take you both by surprise! And yet ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 176,000 newsletter subscribers for 21 days.